1) American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 23 (supplt 1) Clinical Practice Recommendation 2000.
2) Expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes care 1997; 20;1183-97.
3) John L Leahy; Natural history of beta cell dysfunction in NIDDM. Diabetes care 1990; Vol.B Number 9, Review issue 2: 992-1004.
4) UKPDS Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment with type 2 diabetes (UKPDS 33). Lancet 1998:352: 837-853.
5) Dr. S. Kumar & Dr. A.J.M. Boultan; Macrovascular disease; Highlights of 14th IDF congress. June 1991; 9-10.
6) Beverly Balkau, Martin Shipley, R. John Jarrett etal; High blood glucose concentration is a risk factor for mortality in middle aged non diabetic men. Diabetes care. 21( 3): 360-367;1998.
7) Jarrett RJ, Shipley MJ ; Type 2 ( Non insulin dependent ) Diabetes mellitus and Cardiovascular disease putative association via common antecedents; further evidence from the Whitehall study. Diabetologia 31; 737-740; 1988.
8) Harris M. I, Flegal K. M. etal; Prevalence of diabetes, impaired fasting glucose, impaired glucose tolerance in US adults: The third National Health and Nutrition Survey; 1988-1994. Diabetes care 21(4): 518-524;1998.
9) Francisco J Gomex- Perez etal; Lack of agreement between the world health organization category of impaired glucose tolerance and the American Diabetes Association category of Impaired fasting glucose. Diabetes care 21(11):1886-1888;1998.
10) Kroll L.P. Editor World book of diabetes in practice
11) Q. Qiao, T.Nakagami et al; Comparison of fasting and 2-hour glucose criteria for diabetes in different Asian cohorts: Diabetologia 43(12): 1470-1475;2000.
12) Ramachandran A, Snehalatha C et al; Significance of impaired glucose tolerance in Asian Indian Population. A follow-up study. Diab Res Clin Pract 2:173-8;1986.